Here are five things to know:
1. The prospective, multicenter study compared outcomes of 143 patients with LSS and neurogenic claudication due to hypertrophic ligamentum flavum treated with MILD and 131 patients treated with epidural steroid injections.
2. There was no evidence of spinal instability or fractures in patients who underwent the MILD procedure.
3. The MILD procedure had no device- or procedure-related serious adverse events as well as a lower complication rate than more invasive spine procedures.
4. Authors concluded a higher level of safety when using the MILD procedure compared to other spine interventions, such as decompression and fusion.
5. The study also found LSS patients with bulging disc, facet hypertrophy and foraminal narrowing, among other conditions, achieved statistically significant pain relief and mobility improvement. Study authors conclude the presence of those comorbidities should not exclude a patient from being considered for MILD.
More articles on MIS:
Captiva Spine receives FDA clearance for extended tab pedicle screws – 3 things to know
FDA clears Genesys Spine’s AIS-C Stand-Alone System: 4 things to know
BCBS of South Carolina now covers interspinous, interlaminar stabilization to treat lumbar spinal stenosis: 4 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
